AAAAAA

   
Results: 1-15 |
Results: 15
Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer
Authors: Schorge, JO Mahoney, NM Miller, DS Coleman, RL Muller, CY Euhus, DM Tomlinson, GE
Citation: Jo. Schorge et al., Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer, GYNECOL ONC, 83(2), 2001, pp. 383-387
Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix
Authors: Boruta, DM Schorge, JO Duska, LA Crum, CP Castrillon, DH Sheets, EE
Citation: Dm. Boruta et al., Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix, GYNECOL ONC, 81(1), 2001, pp. 82-87
Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum
Authors: Huang, LW Garrett, AP Schorge, JO Muto, MG Bell, DA Welch, WR Berkowitz, RS Mok, SC
Citation: Lw. Huang et al., Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum, AM J CLIN P, 114(1), 2000, pp. 93-99
Conservative management of adenocarcinoma in situ of the cervix
Authors: Shin, CH Schorge, JO Lee, KR Sheets, EE
Citation: Ch. Shin et al., Conservative management of adenocarcinoma in situ of the cervix, GYNECOL ONC, 79(1), 2000, pp. 6-10
Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: A preliminary report
Authors: Schorge, JO Lee, KR Sheets, EE
Citation: Jo. Schorge et al., Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: A preliminary report, GYNECOL ONC, 78(2), 2000, pp. 217-220
The definition of stage IA(1) cervical adenocarcinoma and selection criteria for nonradical surgical management
Authors: Schorge, JO Lee, KR Sheets, EE
Citation: Jo. Schorge et al., The definition of stage IA(1) cervical adenocarcinoma and selection criteria for nonradical surgical management, GYNECOL ONC, 77(2), 2000, pp. 339-339
Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum
Authors: Schorge, JO Miller, YB Qi, LJ Muto, MG Welch, WR Berkowitz, RS Mok, SC
Citation: Jo. Schorge et al., Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum, GYNECOL ONC, 76(3), 2000, pp. 369-372
Recent advances in gestational trophoblastic disease
Authors: Schorge, JO Goldstein, DP Bernstein, MR Berkowitz, RS
Citation: Jo. Schorge et al., Recent advances in gestational trophoblastic disease, J REPRO MED, 45(9), 2000, pp. 692-700
BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis
Authors: Schorge, JO Muto, MG Lee, SJ Huang, LW Welch, WR Bell, DA Keung, EZ Berkowitz, RS Mok, SC
Citation: Jo. Schorge et al., BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis, CANCER RES, 60(5), 2000, pp. 1361-1364
Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers
Authors: Chan, WY Cheung, KK Schorge, JO Huang, LW Welch, WR Bell, DA Berkowitz, RS Mok, SC
Citation: Wy. Chan et al., Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers, AM J PATH, 156(2), 2000, pp. 409-417
Endometrial cancer: Recent developments in evaluation and treatment - The Chen/McGonigle/Berek article reviewed
Authors: Sheets, EE Schorge, JO
Citation: Ee. Sheets et Jo. Schorge, Endometrial cancer: Recent developments in evaluation and treatment - The Chen/McGonigle/Berek article reviewed, ONCOLOGY-NY, 13(12), 1999, pp. 1675-1676
Understanding the pathogenesis of primary peritoneal carcinoma: Involvement of the BRCA1 and p53 genes
Authors: Schorge, JO Mok, SC
Citation: Jo. Schorge et Sc. Mok, Understanding the pathogenesis of primary peritoneal carcinoma: Involvement of the BRCA1 and p53 genes, HUMAN PATH, 30(2), 1999, pp. 115-116
Early cervical adenocarcinoma: Selection criteria for radical surgery
Authors: Schorge, JO Lee, KR Lee, SJ Flynn, CE Goodman, A Sheets, EE
Citation: Jo. Schorge et al., Early cervical adenocarcinoma: Selection criteria for radical surgery, OBSTET GYN, 94(3), 1999, pp. 386-390
Stage IA(1) cervical adenocarcinoma: Definition and treatment
Authors: Schorge, JO Lee, KR Flynn, CE Goodman, A Sheets, EE
Citation: Jo. Schorge et al., Stage IA(1) cervical adenocarcinoma: Definition and treatment, OBSTET GYN, 93(2), 1999, pp. 219-222
Clinically significant venous thromboembolism after gynecologic surgery
Authors: Schorge, JO Goldhaber, SZ Duska, LR Goodman, A Feldman, S
Citation: Jo. Schorge et al., Clinically significant venous thromboembolism after gynecologic surgery, J REPRO MED, 44(8), 1999, pp. 669-673
Risultati: 1-15 |